-+ 0.00%
-+ 0.00%
-+ 0.00%

Photocure partners with Clinigen to expand Hexvix access in over 40 markets

PUBT·11/18/2026 07:05:35
Listen to the news
Photocure partners with Clinigen to expand Hexvix access in over 40 markets
  • Photocure entered an agreement with Clinigen to expand access to Hexvix/Cysview through a named patient program initially covering more than 40 countries.
  • The program targets markets where the bladder cancer diagnostic product is not approved or commercially available.
  • Clinigen will handle global distribution from a central UK warehouse, using product supplied by Photocure.
  • The global rollout follows an initial program established in South Africa in 2024.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Photocure ASA published the original content used to generate this news brief via Cision (Ref. ID: 202611180200BITN____UKPR__EN_20261117-BIT-0555-0) on November 18, 2026, and is solely responsible for the information contained therein.